Targeting intracellular signalling pathways
Onkologe, ISSN: 0947-8965, Vol: 13, Issue: 1, Page: 32-45
2007
- 1Citations
- 9Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Targeting intracellular pathways is a promising new approach in cancer treatment. During tumorigenesis key elements of the intracellular signalling network are altered in their biological activity. Low-molecular-weight compounds directed against the active motifs of kinases or other regulatory proteins therefore open up new therapeutic options, especially in combination with established cancer therapies. © 2006 Springer Medizin Verlag.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33846455045&origin=inward; http://dx.doi.org/10.1007/s00761-006-1159-7; http://link.springer.com/10.1007/s00761-006-1159-7; http://link.springer.com/content/pdf/10.1007/s00761-006-1159-7; http://link.springer.com/content/pdf/10.1007/s00761-006-1159-7.pdf; http://link.springer.com/article/10.1007/s00761-006-1159-7/fulltext.html; https://dx.doi.org/10.1007/s00761-006-1159-7; https://link.springer.com/article/10.1007/s00761-006-1159-7; http://www.springerlink.com/index/10.1007/s00761-006-1159-7; http://www.springerlink.com/index/pdf/10.1007/s00761-006-1159-7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know